Monness Crespi & Hardt upgraded Oracle from Sell to Neutral
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/18/2025 | $220.00 → $250.00 | Buy | Guggenheim |
| 6/13/2025 | $235.00 | Market Perform → Outperform | BMO Capital Markets |
| 6/9/2025 | $175.00 → $200.00 | Market Perform | BMO Capital Markets |
| 4/23/2025 | $130.00 | Overweight → Neutral | Piper Sandler |
| 3/19/2025 | $167.00 | Equal-Weight | Stephens |
| 3/11/2025 | $205.00 → $175.00 | Market Perform | BMO Capital Markets |
| 3/3/2025 | Sell → Neutral | Monness Crespi & Hardt | |
| 1/17/2025 | $214.00 | Overweight | Cantor Fitzgerald |
Guggenheim reiterated coverage of Oracle with a rating of Buy and set a new price target of $250.00 from $220.00 previously
BMO Capital Markets upgraded Oracle from Market Perform to Outperform and set a new price target of $235.00
BMO Capital Markets reiterated coverage of Oracle with a rating of Market Perform and set a new price target of $200.00 from $175.00 previously